Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics. Our platform enables rapid and precise manufacturing of cell-like products using a patented manufacturing and formulation process. Our north star is to help democratize access to advanced diagnostics and therapeutics by eliminating cold-chain restrictions, reducing COGS and improving the quality of end products by leveraging a breakthrough suite of ancillary reagents. 



Join TechBio Companies Driving Patient Impact